secwatch.observer — SEC 8-K summary
======================================

Issuer:     Paysign, Inc. (PAYS)
CIK:        0001496443
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001683168-24-003052
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paysign Q1 revenue $13.2M (+30% YoY); net income $309k vs loss; reaffirms FY guidance
--------------------------------------------------------------------------------

- Total revenue $13.2M, up 30% YoY; net income $309k ($0.01 diluted EPS) vs net loss $160k in Q1 2023.
- Adjusted EBITDA $1.7M, up 135% from $720k; diluted adj. EBITDA per share $0.03 vs $0.01.
- Pharma patient affordability revenue surged 305% YoY; added 10 net new programs, ending quarter with 53 active.
- Plasma revenue up 11% YoY; 469 plasma centers (net +5); avg revenue per center per month $7,414 (+5%).
- Confirms FY 2024 guidance: revenue $54.5M–$56.7M, adjusted EBITDA $8.0M–$9.0M; Q2 revenue expected +27.5% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496443/000168316824003052/0001683168-24-003052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496443/000168316824003052/paysign_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-003052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer